390 related articles for article (PubMed ID: 31810233)
1. Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dore MP; Bibbò S; Fresi G; Bassotti G; Pes GM
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810233
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
Hedin C; Whelan K; Lindsay JO
Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
[TBL] [Abstract][Full Text] [Related]
3. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
[TBL] [Abstract][Full Text] [Related]
4. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Seksik P; Dray X; Sokol H; Marteau P
Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
Chen M; Feng Y; Liu W
Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
[TBL] [Abstract][Full Text] [Related]
6. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
Ganji-Arjenaki M; Rafieian-Kopaei M
J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
[TBL] [Abstract][Full Text] [Related]
7. Probiotics for maintenance of remission in ulcerative colitis.
Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis.
Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM
Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375
[TBL] [Abstract][Full Text] [Related]
9. The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009-2020.
Darb Emamie A; Rajabpour M; Ghanavati R; Asadolahi P; Farzi S; Sobouti B; Darbandi A
J Appl Microbiol; 2021 Jun; 130(6):1823-1838. PubMed ID: 33098703
[TBL] [Abstract][Full Text] [Related]
10. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
Meijer BJ; Dieleman LA
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
[TBL] [Abstract][Full Text] [Related]
12. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
Dang X; Xu M; Liu D; Zhou D; Yang W
PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
Zhang WX; Shi LB; Zhou MS; Wu J; Shi HY
J Med Microbiol; 2023 Sep; 72(9):. PubMed ID: 37772692
[No Abstract] [Full Text] [Related]
14. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Astó E; Méndez I; Audivert S; Farran-Codina A; Espadaler J
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30704039
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of probiotics in inflammatory bowel diseases.
Mach T
J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
[TBL] [Abstract][Full Text] [Related]
16. Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study.
Hedin CR; Mullard M; Sharratt E; Jansen C; Sanderson JD; Shirlaw P; Howe LC; Djemal S; Stagg AJ; Lindsay JO; Whelan K
Inflamm Bowel Dis; 2010 Dec; 16(12):2099-108. PubMed ID: 20848469
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of probiotics in inflammatory bowel disease.
Cain AM; Karpa KD
Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
[TBL] [Abstract][Full Text] [Related]
18. Synbiotics improve clinical indicators of ulcerative colitis: systematic review with meta-analysis.
Rufino MN; da Costa AL; Jorge EN; Paiano VF; Camparoto ML; Keller R; Bremer-Neto H
Nutr Rev; 2022 Jan; 80(2):157-164. PubMed ID: 34010402
[TBL] [Abstract][Full Text] [Related]
19. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
Jonkers D; Penders J; Masclee A; Pierik M
Drugs; 2012 Apr; 72(6):803-23. PubMed ID: 22512365
[TBL] [Abstract][Full Text] [Related]
20. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials.
Fujiya M; Ueno N; Kohgo Y
Clin J Gastroenterol; 2014 Feb; 7(1):1-13. PubMed ID: 26183502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]